UDK: 616.379-008.64:615.272

METABOLIC EFFECTS OF ASTROLIN (INULIN-BASED DRUG) IN PATIENTS WITH DIABETES MELLITUS TYPE 2

P. A. Bakumov, Yu. V. Kozyrenko

Кафедра клинической фармакологии и интенсивной терапии, кафедра общей врачебной практики и профессиональных заболеваний ВолГМУ

Abstract

An investigation of the effect of the inulin-containing medication (Astrolin) on carbohydrate and lipid metabolism in complex therapy of patients with diabetes mellitus type 2 was conducted. When added to the basic therapy of diabetes type 2 it contributed to decrease of glucose blood level by 15 %, glycosylated haemoglo-bin by 10 %, total cholesterol by 13 %, beta-lipoproteids by 12 % and triglyce-rides by 22 %. A good tolerance of the medication was demonstrated in the study. Astrolin is recommended in the complex therapy of patients with diabetes mellitus type 2.

Keywords

diabetes mellitus type 2, inulin, Astrolin, carbohydrate and lipid metabolism.

Contacts

Бакумов Павел Анатольевич - д.м.н., профессор, зав. кафедрой общей врачебной практики и профессиональных заболеваний ВолГМУ, Козыренко Ю.В. – kozyrenis@mail.ru